U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06943989) titled 'Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air at Rest ( LOCONOZ3 )' on April 17.
Brief Summary: The primary purpose of this study is to measure pulmonary function, symptoms, and pulmonary inflammatory responses in healthy young adults during and immediately after exposure to a low concentration of ozone (0.070 ppm) or clean air for 6.6 hours while at rest. This concentration is the current EPA NAAQS standard for ozone.
Study Start Date: Nov. 05, 2024
Study Type: INTERVENTIONAL
Condition:
Lung Inflammation
Experimental Lung Inflammation
Intervention:
OTHER: Ozone Exposure...